Gender-specific differences in the kinetics of nonfasting TRL, IDL, and LDL apolipoprotein B-100 in men and premenopausal women

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 28, Issue 10, 2008, Pages 1838-1843

  Matthan, Nirupa R ^a   Jalbert, Susan M ^a   Barrett, P Hugh R ^b   Dolnikowski, Gregory G ^a   Schaefer, Ernst J ^a   Lichtenstein, Alice H ^a  

^a TUFTS UNIVERSITY   (United States)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Apolipoproteins; CVD; Gender; Metabolism; Stable isotopes

Indexed keywords

APOLIPOPROTEIN B100; INTERMEDIATE DENSITY LIPOPROTEIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIGLYCEROL RICH LIPOPROTEIN; UNCLASSIFIED DRUG; CHOLESTEROL; LIPOPROTEIN TRIGLYCERIDE; TRIACYLGLYCEROL;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CATABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; KINETICS; MALE; PREMENOPAUSE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; BIOLOGICAL MODEL; BLOOD; COMPARATIVE STUDY; METABOLISM; POSTPRANDIAL STATE; RISK FACTOR;

ADULT; APOLIPOPROTEIN B-100; CARDIOVASCULAR DISEASES; CHOLESTEROL; FEMALE; HUMANS; KINETICS; LIPOPROTEINS; LIPOPROTEINS, IDL; LIPOPROTEINS, LDL; MALE; MODELS, BIOLOGICAL; POSTPRANDIAL PERIOD; PREMENOPAUSE; RISK FACTORS; SEX FACTORS; TRIGLYCERIDES;

EID: 53449098100     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/ATVBAHA.108.163931     Document Type: Article

References (51)

1. American Heart Association Writing Group. Heart Disease and Stroke Statistics-2006 Update. A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2006:1-67.
2. Colditz GA, Willett WC, Stampfer MJ, Rosner B, Speizer FE, Hennekens CH. Menopause and the risk of coronary heart disease in women. N Engl J Med. 1987;316:1105-1110.
3. Hsia J, Barad D, Margolis K, Rodabough R, McGovern PG, Limacher MC, Oberman A, Smoller S. Usefulness of prior hysterectomy as an independent predictor of Framingham risk score (The Women's Health Initiative). Am J Cardiol. 2003;92:264-269.
4. Hurst W. The Heart, Arteries and Veins. New York, NY: McGraw-Hill, 2002.
5. National Cholesterol Education Program (NCEP) Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143-3421.
6. Ferrara A, Barrett-Connor E, Shan J. Total, LDL, and HDL cholesterol decrease with age in older men and women. The Rancho Bernardo Study 1984-1994. Circulation. 1997;96:37-43.
7. Godsland IF, Wynn V, Crook D, Miller NE. Sex, plasma lipoproteins, and atherosclerosis: prevailing assumptions and outstanding questions. Am Heart J. 1987;114:1467-1503.
8. Kannel WB. The Framingham Study: historical insight on the impact of cardiovascular risk factors in men versus women. J Gender Spec Med. 2002;5:27-37.
9. Schaefer EA, Lamon-Fava S, Cohn SD, Schaefer MM, Ordovas JM, Castelli WP, F. WPW. Effects of age, gender, and menopausal status on plasma low density lipoprotein cholesterol and apoliporpotein B levels in the Framingham Offspring Study. J Lipid Res. 1994;35:779-792.
10. Stevenson JC, Crook D, Godsland IF. Influence of age and menopause on serum lipids and lipoproteins in healthy women. Atherosclerosis. 1993; 98:83-90.
11. Wilson PW, Anderson KM, Harris T, Kannel WB, Castelli WP. Determinants of change in total cholesterol and HDL-C with age: the Framingham Study. J Gerontol. 1994;49:M252-M257.
12. Bello N, Mosca L. Epidemiology of coronary heart disease in women. Prog Cardiovasc Dis. 2004;46:287-285.
13. Costanza MC, Cayanis E, Ross BM, Flaherty MS, Alvin GB, Das K, Morabia A. Relative contributions of genes, environment, and interactions to blood lipd concentrations in a general adult population. Am J Epidemiol. 2004;161:714-724.
14. Despres JP, Couillard C, Gagnon J, Bergeron J, Leon AS, Rao DC, Skinner JS, Wilmore JH, Bouchard C. Race, visceral adipose tissue, plasma lipids, and lipoprotein lipase activity in men and women. The health, risk factors, exercise training, and genetics (HERITAGE) family study. Arterioscler Thromb Vasc Biol. 2000;20:1932-1938.
15. Gardner CD, Tribble DL, Young DR, Ahn D, Fortmann SP. Population frequency distributions of HDL, HDL2, and HDL3 cholesterol and apolipoproteins A-I and B in healthy men and women and associations with age, gender, hormonal status and sex hormone use: The Stanford Five City Project. Prev Med. 2000;31:335-345.
16. Jousilahti P, Vartiainen E, Tuomilehto J, Puska P. Sex, age. cardiovascular risk factors, and coronary heart disease. A prospective follow-up study of 14,786 middle-aged men and women in Finland. Circulation. 1999;99:1165-1172.
17. Li Z, McNamara JR, Fruchart JC, Luc G, Bard JM, Ordovas JM, Wilson PWF, Schaefer EJ. Effects of gender and menopausal status on plasma lipoprotein subspecies and particle sizes. J Lipid Res. 1996;37: 1886-1896.
18. Campos H, McNamara JR, Wilson PW, Ordovas JM, Schaefer EJ. Differences in low density lipoprotein subfractions and apolipoproteins in premenopausal and postmenopausal women. J Clin Endocrinol Metabol. 1988;67:30-35.
19. Dallongeville J, Marecaux N, Isorez D, Zylbergberg G, Fruchart JC, Amouyel P. Multiple coronary heart disease risk factors are associated with menopause and influenced by substitutive hormonal therapy in a cohort of French women. Atherosclerosis. 1995;118:123-133.
20. Davis CE, Pajak A, Rywik S, Williams DH, Broda G, Pazucha T, Ephross S. Natural menopause and cardiovascular disease risk factors. The Poland and US Collaborative Study on Cardiovascular Disease Epidemiology. Ann Epidemiol. 1994;4:445-448.
21. Nerbrand C, Lidfeldt J, Nyberg P, Schersten B, Samsioe G. Serum lipids and lipoproteins in relation to endogenous and exogenous female sex steroids and age. The Womwn's Health in the Lund Area (WHILA) study. Maturitas. 2004;48:161-169.
22. Peters JC, Lawson KD, Middleton SJ, Triebwasser KC. Assessment of the nutritional effects of olestra, a nonabsorbed fat replacement: summary. J Nutr. 1997;127:1719S-1728S.
23. Poehlman ET, Tout MJ, Ades PA, Rosen CJ. Menopause-associated changes in plasma lipids, insulin-like growth factor I and blood pressure: a longitudinal study. Eur J Clin Invest. 1997;27:322-326.
24. Staessen JA. Ginocchio G, Thijs L, Fagard R. Conventional and ambulatory blood pressure and menopause in a prospective population study. J Hum Hypertens. 1997;11:507-514.
25. Burnette MM, Meilahn E, Wing RR, Kuller LH. Smoking cessation, weight gain, and changes in cardiovascular risk factors during menopause: the Healthy Women Study. Am J Public Health. 1998;88:93-96.
26. Casiglia E, d'Este D, Ginocchio G, Colangeli G, Onesto C, Tramontin P, Ambrosio GB, Pessina AC. Lack of influence of menopause on blood pressure and cardiovascular risk profile: a 16-year longitudinal study concerning a cohort of 568 women. J Hypertens. 1996;14:729-736.
27. Hall G, Collins A, Csemiczky G, Landgren BM. Lipoproteins and BMI: a comparison between women during transition to menopause and regularly menstruating healthy women. Maturitas. 2002;41:177-185.
28. Matthan NR, Jalbert SM, Lamon-Fava S, Dolnikowski GG, Welty FK. Barrett HR, Schaefer EJ, Lichtenstein AH. TRL, IDL, and LDL apolipoprotein B-100 and HDL apolipoprotein A-I kinetics as a function of age and menopausal status. Arterioscler Thromb Vasc Biol. 2005;25: 1691-1696.
29. Millar JS, Lichtenstein AH, Cuchel M, Dolnikowski GG, Hachey DL, Cohn JS, Schaefer EJ. Impact of age on the metabolism of VLDL, IDL and LDL apolipoprotein B-100 in men. J Lipid Res. 1995;36:1155-1167.
30. Lichtenstein AH, Cohn JS, Hachey DL, Millar JS, Ordovas JM, Schaefer EJ. Comparison of deuterated leucine, valine, and lysine in the measurement of human apolipoprotein A-I and B-100 kinetics. J Lipid Res. 1990;31:1693-1701.
31. Warnick GR, Benderson J, Albers JJ. Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. Clin Chem. 1982;28:1379-1388.
32. Havel RJ, Eder HA, Bragdon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest. 1955;34:1345-1353.
33. McNamara JR, Schaefer EJ. Automated enzymatic standardized lipid analyses for plasma and lipoprotein fractions. Clinica Chimica Acta. 1987;166:1-8.
34. Ordovas JM, Peterson JP, Santaniello P, Cohn JS, Wilson PW, Schaefer EJ. Enzyme-linked immunosorbent assay for human plasma apolipoprotein B. J Lipid Res. 1987;28:1216-1224.
35. Velez-Carrasco W, Lichtenstein AH, Barrett PH, Sun Z, Dolnikowski GG, Welty FK, Schaefer EJ. Human apolipoprotein A-I kinetics within triglyceride-rich lipoproteins and high density lipoproteins. J Lipid Res. 1999;40:1695-1700.
36. Velez-Carrasco W, Lichtenstein AH, Welty FK, Li Z, Lamon-Fava S, Dolnikowski GG, Schaefer EJ. Dietary restriction of saturated fat and cholesterol decreases HDL ApoA-I secretion. Arterioscler Thromb Vasc Biol. 1999;19:918-924.
37. Matthan NR, Welty FK, Barrett PH, Harausz C, Dolnikowski GG, Parks JS, Eckel RH, Schaefer EJ, Lichtenstein AH. Dietary hydrogenated fat increases high-density lipoprotein apoA-I catabolism and decreases low-density lipoprotein apoB-100 catabolism in hypercholesterolemic women. Arterioscler Thromb Vasc Biol. 2004;24:1092-1097.
38. Welty FK, Lichtenstein AH, Barrett PH, Dolnikowski GG, Ordovas JM, Schaefer EJ. Decreased production and increased catabolism of apolipoprotein B-100 in apolipoprotein B-67/B-100 heterozygotes. Arterioscler Thromb Vasc Biol. 1997;17:881-888.
39. Parhofer KG, Barrett PHR, Bier DM, Schonfeld G. Determination of kinetic parameters of apolipoprotein B metabolism using amino acids labeled with stable isotopes. J Lipid Res. 1991;32:1311-1323.
40. Ramakrishnan R. Studying apolipoprotein turnover with stable isotope tracers: correct analysis is by modeling enrichments. J Lipid Res. 2006; 47:2738-2753.
41. Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Executive summary of the third report of the National Cholesterol Education Program (NCEP). JAMA. 2001;285:2486-2497.
42. Welty FK, Lichtenstein AH, Barrett PH, Dolnikowski GG, Schaefer EJ. Human apolipoprotein (Apo) B-48 and ApoB-100 kinetics with stable isotopes. Arterioscler Thromb Vasc Biol. 1999;19:2966-2974.
43. Schaefer EJ, Foster DM, Zech LA, Lindgren FT, Brewer HB Jr, Levy RI. The effects of estrogen administration on plasma lipoprotein metabolism in premenopausal females. J Clin Endocrinol Metabol. 1983;57:262-267.
44. Marsh JB, Welty FK, Lichtenstein AH, Lamon-Fava S, Schaefer EJ. Apolipoprotein B metabolism in humans: studies with stable isotope-labeled amino acid precursors. Atherosclerosis. 2002;162:227-244.
45. Watts GF, Moroz P, Barrett PHR. Kinetics of very-low density lipoprotein apolipoprotein B-100 in normolipidemic subjects: pooled analysis of stable isoptope studies. Metabolism. 2000;49:1204-1210.
46. Magkos F, Patterson BW, Mohammed BS, Klein S, Mittendorfer B. Women produce fewer but triglyceride-richer very low density lipoproteins than men. J Clin Endocrinol Metabol. 2006;92:1311-1318.
47. Knopp RH, Paramsothy P, Retzlaff BM, Fish B, Walden C, Dowdy A, Tsunehara C, Aikawa K, Cheung MC. Sex differences in lipoprotein metabolism and dietary response: basis in hormonal differences and implications for cardiovascular disease. Curr Cardiol Rep. 2006;8: 452-459.
48. Walsh BW, Li H, Sacks FM. Effects of postmenopausal hormone replacement with oral and transdermal estrogen on high density lipoprotein metabolism. J Lipid Res. 1994;35:2083-2093.
49. Campos H, Walsh BW, Judge H, Sacks FM. Effect of estrogen on very low density lipoprotein and low density lipoprotein subclass metabolism in postmenopausal women. J Clin Endocrinol Metabol. 1997;82: 3955-3963.
50. William CM. Lipid metabolism in women. Proc Nutr Soc. 2004;63: 153-160.
51. Deeb SS, Zambon A, Carr MC, Ayyobi AF, Brunzell JD. Hepatic lipase and dyslipidemia: interactions among genetic variants, obesity, gender, and diet. J Lipid Res. 2003;44:1279-1286.